Peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-DOTA-TATE in the treatment of malignant insulinoma: a case report of remarkable clinical and imaging response

被引：0
|
作者：
Barbosa, D. [1 ]
Duarte, H. [1 ]
Paula Santos, A. [1 ]
Ferro, J. [1 ]
Prospero, I. [1 ]
Silva, D. [1 ]
Gil-Santos, S. [1 ]
Calheiros, R. [1 ]
Fontao de Castro, S. [1 ]
Ferreira, G. [1 ]
Teixeira, P. [1 ]
Lucena Sampaio, I. [1 ]
机构：
[1] Portuguese Inst Oncol, Oporto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-472
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [31] Induction and Maintenance Regimen with Peptide Receptor Radionuclide Therapy (PRRT) Lu-177-DOTA-TATE (Lu-177) in Patients with Advanced Neuroendocrine Tumours (NET)
    Mc Ewan, A.
    Wieler, M.
    Makis, W.
    McMullen, T.
    Morrish, D.
    MacLeod, S.
    Schrader, L.
    Sawyer, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 94 - 94
  • [32] S-phase enrichment by hydroxyurea treatment enhances [177Lu]Lu-DOTA-TATE uptake in vitro
    Cheng, J.
    Livieratos, L.
    Terry, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S57 - S57
  • [33] Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE
    Mansi, Rosalba
    Plas, Pascale
    Vauquelin, Georges
    Fani, Melpomeni
    PHARMACEUTICALS, 2021, 14 (12)
  • [34] Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
    Simon, Marina
    Jorgensen, Jesper Tranekjaer
    Khare, Harshvardhan A.
    Christensen, Camilla
    Nielsen, Carsten Haagen
    Kjaer, Andreas
    PHARMACEUTICS, 2022, 14 (06)
  • [35] Estimation of kidney doses from [177Lu]Lu-DOTA-TATE PRRT using single time point post-treatment SPECT/CT
    Spink, Safia
    Gillett, Daniel
    Heard, Sarah
    Harper, Ines
    Casey, Ruth
    Aloj, Luigi
    EJNMMI PHYSICS, 2024, 11 (01):
  • [36] Accuracy and Uncertainty Analysis of Reduced Time Point Imaging Effect on Time-Integrated Activity for [177Lu]Lu-DOTA-TATE PRRT in Clinical Patients and Realistic Simulations
    Peterson, A.
    Mirando, D. M.
    Dewaraja, Y. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S404 - S404
  • [37] Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide
    Heute, D. R.
    Dobrozemsky, G.
    Traub, T.
    Warwitz, B.
    von Guggenberg, E.
    Gabriel, M.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S202
  • [38] Lu-177 DOTA-TATE for peptide receptor radionuclide therapy (PRRT): organ-, tumor- and blood kinetics
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S338 - S339
  • [39] Dosimetry in peptide receptor Radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and interpatient variability
    Wehrmann, C.
    Senftleben, S.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S178 - S179
  • [40] Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
    Zavvar, Taraneh Sadat
    Hoermann, Anton Amadeus
    Konijnenberg, Mark
    Kraihammer, Martin
    Mair, Christian
    Kronthaler, Ariane
    Joosten, Lieke
    Laverman, Peter
    Gruber, Leonhard
    di Santo, Gianpaolo
    Decristoforo, Clemens
    Virgolini, Irene
    von Guggenberg, Elisabeth
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1321 - 1331
12345